| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM3012068 |
| P698 | PubMed publication ID | 23145854 |
| P50 | author | Frank M. Boeckler | Q41876113 |
| Rainer Wilcken | Q55686258 | ||
| Andreas C Joerger | Q55686260 | ||
| Andreas Lange | Q63351658 | ||
| P2093 | author name string | Markus O Zimmermann | |
| P2860 | cites work | The Protein Data Bank: a computer-based archival file for macromolecular structures | Q27860989 |
| Angular preferences of intermolecular forces around halogen centers: preferred directions of approach of electrophiles and nucleophiles around carbon-halogen bond | Q30046427 | ||
| The Structure of Bromine 1,4-Dioxanate | Q60191194 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1363-1388 | |
| P577 | publication date | 2013-01-03 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Principles and applications of halogen bonding in medicinal chemistry and chemical biology | |
| P478 | volume | 56 |
| Q42353177 | 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A. |
| Q31039611 | 4R- and 4S-iodophenyl hydroxyproline, 4R-pentynoyl hydroxyproline, and S-propargyl-4-thiolphenylalanine: conformationally biased and tunable amino acids for bioorthogonal reactions |
| Q38948328 | 6,8-Di-bromo-4-oxo-4H-chromene-3-carbaldehyde |
| Q41807749 | 6,8-Di-chloro-4-oxochromene-3-carbalde-hyde |
| Q39269637 | 6,8-Di-iodo-4-oxo-4H-chromene-3-carbalde-hyde |
| Q39273860 | 6-Bromo-4-oxo-4H-chromene-3-carb-alde-hyde |
| Q41996161 | 6-Chloro-7-fluoro-4-oxo-4H-chromene-3-carbaldehyde |
| Q41996166 | 6-Chloro-7-methyl-4-oxo-4H-chromene-3-carbaldehyde |
| Q39272288 | 6-Chloro-8-nitro-4-oxo-4H-chromene-3-carbaldehyde |
| Q39272888 | 6-Fluoro-4-oxo-4H-chromene-3-carbalde-hyde |
| Q41996180 | 6-Iodo-4-oxo-4H-chromene-3-carbaldehyde |
| Q41996146 | 7-Chloro-4-oxo-4H-chromene-3-carbaldehyde |
| Q55274525 | 79/81Br nuclear quadrupole resonance spectroscopic characterization of halogen bonds in supramolecular assemblies. |
| Q41996182 | 8-Chloro-4-oxo-4H-chromene-3-carbaldehyde |
| Q41996172 | 8-Fluoro-4-oxo-4H-chromene-3-carbalde-hyde |
| Q35878817 | 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells. |
| Q90399144 | A Halogen Bonding Perspective on Iodothyronine Deiodinase Activity |
| Q41687880 | A Halogen-Bond-Induced Triple Helicate Encapsulates Iodide |
| Q27728053 | A Modified P1 Moiety Enhances in vitro Antiviral Activity against Various Multi-Drug-Resistant HIV-1 Variants and in vitro CNS Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413 |
| Q54976046 | A Novel Action of Endocrine-Disrupting Chemicals on Wildlife; DDT and Its Derivatives Have Remained in the Environment. |
| Q28539737 | A Protein Data Bank survey reveals shortening of intermolecular hydrogen bonds in ligand-protein complexes when a halogenated ligand is an H-bond donor |
| Q90190303 | A Second Look at the Crystal Structures of Drosophila melanogaster Acetylcholinesterase in Complex with Tacrine Derivatives Provides Insights Concerning Catalytic Intermediates and the Design of Specific Insecticides |
| Q42328355 | A new serotonin 5-HT6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding. |
| Q47875070 | A polarizable ellipsoidal force field for halogen bonds |
| Q49804565 | A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors |
| Q52558518 | Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. |
| Q41515537 | Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition |
| Q57744745 | Asymmetric bifurcated halogen bonds |
| Q42319285 | Atom interaction propensities of oxygenated chemical functions in crystal packings |
| Q38978670 | Benchmarking DFT methods with small basis sets for the calculation of halogen-bond strengths. |
| Q93092071 | Benchmarking of Halogen Bond Strength in Solution with Nickel Fluorides: Bromine versus Iodine and Perfluoroaryl versus Perfluoroalkyl Donors |
| Q92242417 | Biocatalytic Carbon-Hydrogen and Carbon-Fluorine Bond Cleavage through Hydroxylation Promoted by a Histidyl-Ligated Heme Enzyme |
| Q40786331 | Bioisosteric Exchange of Csp3 -Chloro and Methyl Substituents: Synthesis and Initial Biological Studies of Atpenin A5 Analogues |
| Q46633902 | Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors |
| Q56979241 | Chalcogen Bonding in Protein-Ligand Complexes: PDB Survey and Quantum Mechanical Calculations |
| Q46324304 | Characterizing the interplay of Pauli repulsion, electrostatics, dispersion and charge transfer in halogen bonding with energy decomposition analysis |
| Q50524940 | Comparative study of non-covalent interactions between cationic N-phenylviologens and halides by electrochemistry and NMR: the halogen bonding effect. |
| Q48370229 | Competition between Halogen, Hydrogen and Dihydrogen Bonding in Brominated Carboranes. |
| Q53315159 | Competition between hydrogen and halogen bonding in halogenated 1-methyluracil: Water systems. |
| Q58587031 | Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics |
| Q54134346 | Computational insights into the photocyclization of diclofenac in solution: effects of halogen and hydrogen bonding. |
| Q57039732 | Computer-Aided Studies for Novel Arylhydantoin 1,3,5-Triazine Derivatives as 5-HT₆ Serotonin Receptor Ligands with Antidepressive-Like, Anxiolytic and Antiobesity Action In Vivo |
| Q87133063 | Concerted halogen bonding and orthogonal metal-halogen interactions in dimers of lithium formamidinate and halogenated formamidines: an ab initio study |
| Q92542509 | Could Quantum Mechanical Properties Be Reflected on Classical Molecular Dynamics? The Case of Halogenated Organic Compounds of Biological Interest |
| Q51034290 | Could the "Janus-like" properties of the halobenzene CX bond (X=Cl, Br) be leveraged to enhance molecular recognition? |
| Q36893698 | Coumarin Derivatives as Substrate Probes of Mammalian Cytochromes P450 2B4 and 2B6: Assessing the Importance of 7-Alkoxy Chain Length, Halogen Substitution, and Non-Active Site Mutations |
| Q47113841 | Counterion influence on the N-I-N halogen bond. |
| Q28543133 | Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design |
| Q41894260 | Crystal structure of 6,7-di-chloro-4-oxo-4H-chromene-3-carbaldehyde |
| Q41995239 | Crystal structure of 6-bromo-7-fluoro-4-oxo-4H-chromene-3-carbaldehyde |
| Q41995225 | Crystal structure of 7,8-di-chloro-4-oxo-4H-chromene-3-carbaldehyde |
| Q41996109 | Crystal structure of 7-bromo-4-oxo-4H-chromene-3-carbaldehyde |
| Q41994929 | Crystal structure of 7-iodo-4-oxo-4H-chromene-3-carbaldehyde |
| Q41947033 | Crystal structure of 8-bromo-4-oxo-4H-chromene-3-carbaldehyde |
| Q27677359 | Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections |
| Q92013749 | Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition |
| Q48656177 | Design, semisynthesis and potent cytotoxic activity of novel 10-fluorocamptothecin derivatives |
| Q57242712 | Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors |
| Q38967201 | Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies |
| Q38914579 | Development of novel aminothiazole-comprising 5-LO inhibitors |
| Q51039534 | Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter. |
| Q52839630 | Direct Experimental Evidence for Halogen-Aryl π Interactions in Solution from Molecular Torsion Balances. |
| Q40523781 | Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods |
| Q38882751 | Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore |
| Q46541638 | Electrochemical activation of a tetrathiafulvalene halogen bond donor in solution |
| Q34402198 | Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues |
| Q64226664 | Embracing the Diversity of Halogen Bonding Motifs in Fragment-Based Drug Discovery-Construction of a Diversity-Optimized Halogen-Enriched Fragment Library |
| Q39786189 | Enhancing a CH-π Interaction to Increase the Affinity for 5-HT1A Receptors |
| Q35005970 | Evidence for halogen bond covalency in acyclic and interlocked halogen-bonding receptor anion recognition |
| Q60187324 | Expanding the SAR of Nontoxic Antiplasmodial Indolyl-3-ethanone Ethers and Thioethers |
| Q47623436 | Expanding the applicability of electrostatic potentials to the realm of transition states |
| Q40352580 | Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere |
| Q58500452 | Experimental and computational evidence of halogen bonds involving astatine |
| Q42069894 | Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation. |
| Q57818362 | Exploring Halogen Bonds in 5-Hydroxytryptamine 2B Receptor-Ligand Interactions |
| Q47162627 | Exploring the (Very Flat) Potential Energy Landscape of R-Br⋅⋅⋅π Interactions with Accurate CCSD(T) and SAPT Techniques. |
| Q86928612 | Exploring the C-X…π halogen bonding motif: an infrared and Raman study of the complexes of CF₃X (X = Cl, Br and I) with the aromatic model compounds benzene and toluene |
| Q38812479 | Flexibility is important for inhibition of the MDM2/p53 protein-protein interaction by cyclic β-hairpins |
| Q36320965 | Fluoride-containing podophyllum derivatives exhibit antitumor activities through enhancing mitochondrial apoptosis pathway by increasing the expression of caspase-9 in HeLa cells |
| Q89782502 | Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53 |
| Q37349746 | Force Field Model of Periodic Trends in Biomolecular Halogen Bonds |
| Q45062963 | Gas phase hydration of halogenated benzene cations. Is it hydrogen or halogen bonding? |
| Q40444472 | Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects. |
| Q55432495 | HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment. |
| Q57027788 | Halogen Bond Asymmetry in Solution |
| Q41012447 | Halogen Bonding: A Powerful Tool for Modulation of Peptide Conformation. |
| Q89465838 | Halogen Bonds in Ligand-Protein Systems: Molecular Orbital Theory for Drug Design |
| Q59809123 | Halogen and Hydrogen Bonding Interplay in the Crystal Packing of Halometallocenes |
| Q92527762 | Halogen and Hydrogen Bonding in Halogenabenzene/NH3 Complexes Compared Using Next-Generation QTAIM |
| Q54239622 | Halogen bonded supramolecular capsules: a challenging test case for quantum chemical methods. |
| Q38686075 | Halogen bonding in medicinal chemistry: from observation to prediction |
| Q86028014 | Halogen bonding in water results in enhanced anion recognition in acyclic and rotaxane hosts |
| Q40899852 | Halogen bonding molecular capsules |
| Q47341937 | Halogen bonding properties of 4-iodopyrazole and 4-bromopyrazole explored by rotational spectroscopy and ab initio calculations |
| Q52845093 | Halogen transfer through halogen bonds in halogen-bound ammonia homodimers. |
| Q35071812 | Halogen- and hydrogen-bonded salts and co-crystals formed from 4-halo-2,3,5,6-tetrafluorophenol and cyclic secondary and tertiary amines: orthogonal and non-orthogonal halogen and hydrogen bonding, and synthetic analogues of halogen-bonded biologica |
| Q48130685 | Halogen-Bonded Supramolecular Capsules in the Solid State, in Solution, and in the Gas Phase |
| Q41727207 | Halogen-directed drug design for Alzheimer's disease: a combined density functional and molecular docking study. |
| Q35181268 | Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery |
| Q46088734 | Halogen-π Interactions in the Cytochrome P450 Active Site: Structural Insights into Human CYP2B6 Substrate Selectivity. |
| Q90391581 | Halogenation-guided chemical screening provides insight into tjipanazole biosynthesis by the cyanobacterium Fischerella ambigua |
| Q56970085 | High-Level Quantum Chemistry Empowers the Wrapping Technology for Drug Design |
| Q92674152 | Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction |
| Q90367172 | Hydration of Aromatic Heterocycles as an Adversary of π-Stacking |
| Q38892415 | Identification of a putative binding site critical for general anesthetic activation of TRPA1. |
| Q50442086 | Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners. |
| Q48156983 | Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2 -Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation |
| Q27679833 | Identifying ligand-binding hot spots in proteins using brominated fragments |
| Q64924222 | Increasing Enzyme Stability and Activity through Hydrogen Bond-Enhanced Halogen Bonds. |
| Q47703266 | Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design. |
| Q90335224 | Inhibitory Effects of Novel 7-Substituted 6-iodo-3-O-Flavonol Glycosides against Cholinesterases and β-secretase Activities, and Evaluation for Potential Antioxidant Properties |
| Q48358876 | Insights into Thiol-Aromatic Interactions: A Stereoelectronic Basis for S-H/π Interactions. |
| Q92970225 | Interplay between Halogen Bonding and Lone Pair-π Interactions: A Computational and Crystal Packing Study |
| Q43759660 | Intramolecular halogen-halogen bonds? |
| Q41569783 | Investigating the Biosynthesis of Natural Products from Marine Proteobacteria: A Survey of Molecules and Strategies |
| Q38809555 | Iodoalkyne-Based Catalyst-Mediated Activation of Thioamides through Halogen Bonding |
| Q64267960 | Is the Fluorine in Molecules Dispersive? Is Molecular Electrostatic Potential a Valid Property to Explore Fluorine-Centered Non-Covalent Interactions? |
| Q41077244 | Isomorphous crystal structures of chlorodi-acetyl-ene and iododi-acetyl-ene derivatives: simultaneous hydrogen and halogen bonds on carbon-yl |
| Q37539924 | Mastering tricyclic ring systems for desirable functional cannabinoid activity |
| Q88051236 | Modelling Charge Transfer in Weak Chemical Bonds: Insights from the Chemistry of Helium |
| Q30863658 | Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition |
| Q38335784 | Molecular recognition in chemical and biological systems |
| Q52838984 | Molecular recognition of thiaclopride by Aplysia californica AChBP: new insights from a computational investigation. |
| Q35139331 | N-arylated-lactam-type iminosugars as new immunosuppressive agents: discovery, optimization, and biological evaluation. |
| Q42315611 | Neutral iodotriazoles as scaffolds for stable halogen-bonded assemblies in solution |
| Q38260066 | Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014). |
| Q35228409 | Novel hinge-binding motifs for Janus kinase 3 inhibitors: a comprehensive structure-activity relationship study on tofacitinib bioisosteres. |
| Q91627052 | On the Interplay between Charge-Shift Bonding and Halogen Bonding |
| Q48177352 | One-Pot, Metal-Free Conversion of Anilines to Aryl Bromides and Iodides. |
| Q93252432 | Optically active iodohelicene derivatives exhibit histamine N-methyl transferase inhibitory activity |
| Q50850382 | Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2. |
| Q90737973 | Predicting the Magnitude of σ-Holes Using VmaxPred, a Fast and Efficient Tool Supporting the Application of Halogen Bonds in Drug Discovery |
| Q50599275 | Predictive Models for Halogen-bond Basicity of Binding Sites of Polyfunctional Molecules. |
| Q48096715 | Quantum Chemical Dissection of the Shortest P=O⋅⋅⋅I Halogen Bond: The Decisive Role of Crystal Packing Effects. |
| Q56969997 | Quantum Mechanical Concepts for Epistructural Drug Design |
| Q36438686 | Rapid experimental SAD phasing and hot-spot identification with halogenated fragments |
| Q28384766 | Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa |
| Q53459486 | Regioselective Synthesis of Polyheterohalogenated Naphthalenes via the Benzannulation of Haloalkynes. |
| Q39210894 | Relationships between hydrogen bonds and halogen bonds in biological systems. |
| Q37159748 | Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay |
| Q28543910 | SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest |
| Q90982209 | Scaffold Effects on Halogen Bonding Strength |
| Q46403976 | Scaffold dependencies for halogen bonding: quantum mechanical investigation of nitrogen-bearing heterocycles. |
| Q92705480 | Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus |
| Q55015070 | Self-complementary nickel halides enable multifaceted comparisons of intermolecular halogen bonds: fluoride ligands vs. other halides. |
| Q90448211 | Separation of halogenated benzenes enabled by investigation of halogen-π interactions with carbon materials |
| Q47224821 | Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549. |
| Q37679508 | Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux |
| Q38718959 | Stereoselective Halogenation in Natural Product Synthesis |
| Q46333329 | Strength, character, and directionality of halogen bonds involving cationic halogen bond donors |
| Q34550666 | Structural Analysis of Chemokine Receptor-Ligand Interactions |
| Q38995743 | Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles. |
| Q53750464 | Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands. |
| Q44742890 | Structure and energetics of gas phase halogen-bonding in mono-, bi-, and tri-dentate anion receptors as studied by BIRD. |
| Q40968408 | Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors |
| Q41722014 | Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists |
| Q27680709 | Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase |
| Q28830478 | Substituent Effects on the [N-I-N](+) Halogen Bond |
| Q47161171 | Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases |
| Q94531465 | Synthesis and Biological Evaluation of Endocannabinoid Uptake Inhibitors Derived from WOBE437 |
| Q60950063 | Synthesis and Evaluation of the 4-Substituted 2-Hydroxy-5-Iodochalcones and Their 7-Substituted 6-Iodoflavonol Derivatives for Inhibitory Effect on Cholinesterases and β-Secretase |
| Q47132043 | Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands |
| Q90494485 | Synthesis of Halogenated Anilines by Treatment of N, N-Dialkylaniline N-Oxides with Thionyl Halides |
| Q64251177 | Synthesis of New Derivatives of Benzofuran as Potential Anticancer Agents |
| Q66829251 | Synthesis of a novel brominated vinylic fatty acid with antileishmanial activity that effectively inhibits the Leishmania topoisomerase IB enzyme mediated by halogen bond formation |
| Q27680754 | Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain |
| Q50161006 | The Affinity of Brominated Phenolic Compounds for Human and Zebrafish Thyroid Receptor β: Influence of Chemical Structure |
| Q58444977 | The Dominant Role of Chalcogen Bonding in the Crystal Packing of 2D/3D Aromatics |
| Q92282757 | The Significance of Halogen Bonding in Ligand-Receptor Interactions: The Lesson Learned from Molecular Dynamic Simulations of the D4 Receptor |
| Q34238780 | The effect of bromine scanning around the phenyl group of 4-phenylquinolone derivatives |
| Q47908788 | The evaluation of QM/MM-driven molecular docking combined with MM/GBSA calculations as a halogen-bond scoring strategy |
| Q36203959 | The intrinsic strength of the halogen bond: electrostatic and covalent contributions described by coupled cluster theory |
| Q51832859 | The properties of substituted 3D-aromatic neutral carboranes: the potential for σ-hole bonding. |
| Q89497559 | Theoretical Study on the Sensing Mechanism of Novel Hydrazine Sensor TAPHP and Its ESIPT and ICT Processes |
| Q57268117 | Theoretical and experimental characterization of 1,4-N⋯S σ-hole intramolecular interactions in bioactive N-acylhydrazone derivatives |
| Q99594721 | Thyroxine binding to type III iodothyronine deiodinase |
| Q94550873 | Tungstate-Catalyzed Biomimetic Oxidative Halogenation of (Hetero)Arene under Mild Condition |
| Q91845724 | U.S. Food and Drug Administration-Certified Food Dyes as Organocatalysts in the Visible Light-Promoted Chlorination of Aromatics and Heteroaromatics |
| Q55259526 | Understanding and Improving the Activity of Flavin-Dependent Halogenases via Random and Targeted Mutagenesis. |
| Q53508528 | Unusual bonding modes of perfluorobenzene in its polymeric (dimeric, trimeric and tetrameric) forms: entirely negative fluorine interacting cooperatively with entirely negative fluorine. |
| Q38666825 | Validated scoring of halogen bonding in molecular design |
| Q50895789 | Very strong (-)N-X(+)(-)O-N(+) halogen bonds. |
| Q40521899 | WONKA: objective novel complex analysis for ensembles of protein-ligand structures. |
| Q97069665 | π covalency in the halogen bond |
Search more.